1. Home
  2. BCTX vs TSE Comparison

BCTX vs TSE Comparison

Compare BCTX & TSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BriaCell Therapeutics Corp.

BCTX

BriaCell Therapeutics Corp.

HOLD

Current Price

$4.33

Market Cap

17.0M

Sector

Health Care

ML Signal

HOLD

Logo Trinseo PLC

TSE

Trinseo PLC

HOLD

Current Price

$0.47

Market Cap

19.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCTX
TSE
Founded
2014
2010
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
17.0M
19.9M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
BCTX
TSE
Price
$4.33
$0.47
Analyst Decision
Strong Buy
Hold
Analyst Count
1
1
Target Price
$40.00
$1.00
AVG Volume (30 Days)
858.8K
1.7M
Earning Date
03-11-2026
02-11-2026
Dividend Yield
N/A
4.21%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$3,133,800,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$380.95
$4.11
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.10
$0.43
52 Week High
$98.20
$5.99

Technical Indicators

Market Signals
Indicator
BCTX
TSE
Relative Strength Index (RSI) 37.42 37.77
Support Level $4.10 $0.44
Resistance Level $4.56 $0.95
Average True Range (ATR) 0.71 0.09
MACD -0.25 -0.00
Stochastic Oscillator 3.12 7.08

Price Performance

Historical Comparison
BCTX
TSE

About BCTX BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

About TSE Trinseo PLC

Trinseo PLC is a materials company and manufacturer of latex and plastics products. The company's operating segments include Latex Binders, Americas Styrenics, Engineered Materials, and Polymer Solutions. Maximum revenue is generated from its Polymer Solutions segment, which consists of various polymers, the majority of which are for automotive, building, and construction applications. The product offerings of this segment include ABS, styrene-acrylonitrile, polystyrene, and polycarbonate products, which are marketed through brands like Magnum and Styron. Geographically, the company generates maximum revenue from Europe, followed by the United States, Asia-Pacific, and the Rest of the world.

Share on Social Networks: